Aac Holdings, Inc. Receivables Turnover Ratio (AACH), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aac Holdings, Inc.  (AACH)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Aac Holdings Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Aac Holdings, Inc.'s ability to collect accounts receivable sequentially worsen to 4.73, indicating more challenging environment then in the second quarter 2019, but still, it is a far cry from any concerns. Aac Holdings's Accounts Receivable average collection period in the Sep 30 2019 quarter, has increased to 77 days, from 74 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 403 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 2981 to 2993.

What is Receivable Turnover Ratio?
What is Aac Holdings, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AACH Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change -12.84 % -31.4 % -36.5 % -24.92 % 1.58 %
Y / Y Revenue Change -24.03 % -27.7 % -29.44 % -38.4 % -3.67 %
Receivable Turnover Ratio (TTM) 4.73 4.92 4.86 4.72 4.93
AACH's Total Ranking # 2993 # 2981 # 2980 # 2877 # 2878
Accounts Receivable average collection period days 77 74 75 77 74
Seq. Receivable Change 6.99 % 6.7 % -4.55 % -20.02 % -15.79 %
Seq. Revenue Change -6.17 % 13.28 % 4.36 % -31.52 % -10.71 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 38
Healthcare Sector # 404
Overall Market # 2993

Receivable Turnover Ratio Statistics
High Average Low
5.34 3.12 -3.28
(Sep 30 2014)   (Jun 30 2015)





AACH Company Profile • Back to AACH Efficiency Comparisons • Compare AACH Receivables Turnover Ratio to its Competitors

Financial Statements
Aac Holdings's Accounts Receivable $ 52 Millions Visit AACH's Balance sheet
Aac Holdings's Sales TTM $ 230 Millions Visit AACH's Income Statement
Sources of AACH's Revenues Visit AACH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AACH's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AACH's Growth Rates AACH's Roa AACH's Inventory Turnover Ratio AACH's Dividend Comparisons
AACH's Profitability Ratios AACH's Roi AACH's Asset Turnover Ratio AACH's Dividend Growth
AACH's Valuation Ratios AACH's Roe AACH's Financial Strength Ratios AACH's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Lifeloc Technologies Inc   12.09 $ 8.715  Millions$ 0.721  Millions
Travere Therapeutics Inc   11.97 $ 172.421  Millions$ 14.399  Millions
La Jolla Pharmaceutical Company  11.95 $ 19.988  Millions$ 1.673  Millions
Zynex inc   11.84 $ 40.647  Millions$ 3.433  Millions
Ontrak Inc   11.78 $ 28.961  Millions$ 2.458  Millions
Exact Sciences Corporation  11.69 $ 723.699  Millions$ 61.882  Millions
The Pennant Group Inc   11.69 $ 88.398  Millions$ 7.562  Millions
Karyopharm Therapeutics Inc   11.61 $ 23.003  Millions$ 1.982  Millions
Rigel Pharmaceuticals Inc  11.60 $ 81.745  Millions$ 7.044  Millions
Neuronetics Inc   11.50 $ 60.935  Millions$ 5.300  Millions
Paratek Pharmaceuticals Inc   11.22 $ 24.594  Millions$ 2.192  Millions
China Pharma Holdings Inc  11.09 $ 11.118  Millions$ 1.003  Millions
Surmodics Inc   10.98 $ 100.077  Millions$ 9.112  Millions
Tivity Health Inc   10.88 $ 1,011.405  Millions$ 92.931  Millions
Scienture Holdings Inc   10.88 $ 7.034  Millions$ 0.647  Millions
Akebia Therapeutics Inc   10.52 $ 325.296  Millions$ 30.911  Millions
Teladoc Health Inc   10.52 $ 519.559  Millions$ 49.405  Millions
Glaukos Corp  10.51 $ 225.211  Millions$ 21.420  Millions
Insulet Corporation  10.51 $ 693.713  Millions$ 65.990  Millions
Catalyst Pharmaceuticals Inc   10.49 $ 72.684  Millions$ 6.931  Millions
Rockwell Medical inc   10.36 $ 62.667  Millions$ 6.051  Millions
Myomo Inc   10.28 $ 3.207  Millions$ 0.312  Millions
Procyon Corporation  10.26 $ 4.284  Millions$ 0.417  Millions
National Healthcare Corp  10.24 $ 991.423  Millions$ 96.845  Millions
Acorda Therapeutics Inc   10.22 $ 211.064  Millions$ 20.661  Millions
Sutro Biopharma Inc   10.18 $ 50.517  Millions$ 4.965  Millions
Acadia Pharmaceuticals Inc   10.13 $ 300.321  Millions$ 29.658  Millions
Patterson Companies Inc   10.09 $ 5,580.846  Millions$ 553.306  Millions
Fresh Tracks Therapeutics Inc   10.05 $ 7.372  Millions$ 0.733  Millions
Icagen, Inc.  9.95 $ 14.084  Millions$ 1.416  Millions

Date modified: 2026-10-15T05:23:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.